Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

Harian Intens 1 jam yang lalu
187
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market
Bacakan Artikel

Intens.id,

 Everest Medicines (HKEX 1952.HK) announced that it has entered into a commercialization license agreement with ...
Baca Juga
Rekomendasi
Read More

Post Tags